Transactions

March 6, 2014
Recro Pharma, Inc.

Recro Pharma, Inc.

$34.5 Million

IPO Sole Book-Runner
March 4, 2014
Ceres, Inc.

Ceres, Inc.

$23 Million

Secondary/Follow-On Sole Book-Runner
February 20, 2014
Semler Scientific, Inc.

Semler Scientific, Inc.

$10 Million

IPO Sole Book-Runner
February 13, 2014
GlobeImmune, Inc.

GlobeImmune, Inc.

$7.5 Million

Private Placement
February 10, 2014
NephroGenex, Inc.

NephroGenex, Inc.

$37.2 Million

IPO Sole Book-Runner
February 6, 2014
BioBlast Pharma Ltd.

BioBlast Pharma Ltd.

$4.8 Million

Private Placement
February 4, 2014
Biocept, Inc.

Biocept, Inc.

$19 Million

IPO Joint Book-Runner
January 30, 2014
SMTP, Inc.

SMTP, Inc.

$11.5 Million

Secondary/Follow-On Sole Book-Runner
January 30, 2014
CytRx Corporation

CytRx Corporation

$86.3 Million

Secondary/Follow-On
January 23, 2014
Akers Biosciences, Inc.

Akers Biosciences, Inc.

$15 Million

IPO Sole Book-Runner
January 23, 2014
Kips Bay Medical, Inc.

Kips Bay Medical, Inc.

$4.2 Million

Secondary/Follow-On Sole Book-Runner
January 8, 2014
Intellicheck Mobilisa, Inc.

Intellicheck Mobilisa, Inc.

$6.1 Million

Secondary/Follow-On Sole Book-Runner
December 31, 2013
Fusion Telecommunications Int'l, Inc.

Fusion Telecommunications Int'l, Inc.

$44 Million

Private Placement Sole Placement Agent
December 24, 2013
Oramed Pharmaceuticals, Inc.

Oramed Pharmaceuticals, Inc.

$15.8 Million

Registered Direct Sole Placement Agent
December 19, 2013
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

$17.7 Million

Block Trade
December 19, 2013
SuperCom Ltd.

SuperCom Ltd.

$13.8 Million

Secondary/Follow-On Sole Book-Runner

Note: Transactions occurring before April 1, 2018 executed prior to joining ThinkEquity, a Division of Fordham Financial Management., Inc.